BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9577643)

  • 1. [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].
    Iwami H; Misawa A; Tsunamoto K; Kasubuchi Y; Naya M; Hojo M; Goto T; Hibi S; Matsumura T; Todo S; Imashuku S
    Rinsho Ketsueki; 1998 Mar; 39(3):198-204. PubMed ID: 9577643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
    Imashuku S; Goto T; Matsumura T; Naya M; Yamori M; Hojo M; Hibi S; Todo S
    Bone Marrow Transplant; 1997 Aug; 20(4):337-40. PubMed ID: 9285550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
    Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
    Pondarré C; Kebaili K; Dijoud F; Basset T; Philippe N; Bertrand Y
    Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemia.
    Wang LC; Lu MY; Yu J; Jou ST; Chiang IP; Lin KH; Lin DT
    Bone Marrow Transplant; 2000 Oct; 26(8):893-7. PubMed ID: 11081391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
    Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
    Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
    [No Abstract]   [Full Text] [Related]  

  • 8. Remission of a lymphoproliferative disorder occurring after second BMT from an unrelated donor in a 5-year-old boy with severe aplastic anemia.
    Bader P; Klingebiel T; Klingel K; Föll J; Beck J; Handgretinger R; Ehninger G; Deeg HJ; Niethammer D
    Bone Marrow Transplant; 1995 Sep; 16(3):479-81. PubMed ID: 8535324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens.
    Peres E; Savasan S; Klein J; Abidi M; Dansey R; Abella E
    J Clin Microbiol; 2005 Jul; 43(7):3540-3. PubMed ID: 16000501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.
    Ohga S; Kanaya Y; Maki H; Takada H; Ohshima K; Kanda M; Nomura A; Suminoe A; Matsuzaki A; Hara T
    Bone Marrow Transplant; 2000 Jan; 25(2):209-12. PubMed ID: 10673683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation.
    Aisa Y; Mori T; Nakazato T; Suzuki S; Suzuki N; Ikeda Y; Okamoto S
    Transpl Infect Dis; 2009 Oct; 11(5):438-41. PubMed ID: 19497045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia.
    Rudzki Z; Werda L; Piatkowska-Jakubas B; Mensah P; Zazula M; Białas M; Skotnicki AB; Stachura J
    Pol J Pathol; 2002; 53(1):35-40. PubMed ID: 12014224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
    Cox KL; Lawrence-Miyasaki LS; Garcia-Kennedy R; Lennette ET; Martinez OM; Krams SM; Berquist WE; So SK; Esquivel CO
    Transplantation; 1995 Feb; 59(4):524-9. PubMed ID: 7533344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain.
    Nagafuji K; Eto T; Hayashi S; Oshima K; Maeda Y; Gondo H; Inamura T; Niho Y
    Bone Marrow Transplant; 1998 Jun; 21(11):1155-8. PubMed ID: 9645581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
    Witherspoon RP; Deeg HJ; Storb R
    Transplant Sci; 1994 Sep; 4(1):33-41. PubMed ID: 7804695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
    Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
    Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.
    Juvonen E; Aalto SM; Tarkkanen J; Volin L; Mattila PS; Knuutila S; Ruutu T; Hedman K
    Bone Marrow Transplant; 2003 Jul; 32(1):97-102. PubMed ID: 12815484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.